J Gynecol Oncol.  2019 May;30(3):e41. 10.3802/jgo.2019.30.e41.

Preoperative chemoradiation followed by hysterectomy for cervical cancer: patterns of care and survival in a large, hospital database

Affiliations
  • 1Department of Radiation Oncology, University of Mississippi Medical Center, Jackson, MS, USA. aalbert@umc.edu
  • 2Department of Radiation Oncology, SUNY Downstate Medical Center, Brooklyn, NY, USA.
  • 3Department of Veterans Affairs, New York Harbor Healthcare System, Brooklyn, NY, USA.

Abstract


OBJECTIVE
Adjuvant hysterectomy following chemoradiation (CRT) is a treatment option used worldwide for early-stage cervical cancer but the benefit of hysterectomy in this setting is unclear. An analysis of the National Cancer Database (NCDB) was performed to identify patterns of care and determine the survival impact of adjuvant hysterectomy.
METHODS
The NCDB was queried for patients with International Federation of Gynecology and Obstetrics stage IB2 to IIA2 cervical cancer diagnosed from 2010-2014 who underwent preoperative concurrent chemoradiation followed by hysterectomy (CRT+S) or definitive CRT. Overall survival (OS) curves were generated using the Kaplan-Meier method and compared via the log-rank test. Univariable and multivariable logistic regression and Cox regression were used to determine covariables associated with utilization and OS.
RESULTS
There were 1,546 patients who met the study criteria, of which 1,407 (91.0%) received concurrent CRT alone and 139 (9.0%) received CRT+S. Four-year OS for the CRT+S group was 82.2% and 74.9% for the CRT group (p=0.036). On subgroup analysis by lymph node status, the 4-year OS for patients without positive pelvic or para-aortic lymph nodes was 84.9% in the CRT+S group vs. 77.8% in the CRT group (p=0.072). On multivariable Cox regression, there was no difference in survival based on treatment group (hazard ratio=0.63; 95% confidence interval=0.06-1.04; p=0.069).
CONCLUSION
We found from this hospital database that completion hysterectomy is used infrequently and did not result in a significant survival difference when accounting for other factors.

Keyword

Cervical Cancer; Multimodal Treatment; Hysterectomy

MeSH Terms

Combined Modality Therapy
Gynecology
Humans
Hysterectomy*
Logistic Models
Lymph Nodes
Methods
Obstetrics
Uterine Cervical Neoplasms*
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr